The study regarding endoscopic findings affected on the gastric mucosa with spraying L menthol
Not Applicable
- Conditions
- atrophic gastritis
- Registration Number
- JPRN-UMIN000010859
- Lead Sponsor
- Ichinomiya Nishi Hospital Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The following exclusion criteria were applied to patients: previous surgery involving the UGI tract, UGI bleeding requiring hemostasis, scheduled endoscopic surgery, high volume gastric residual and a history of hypersensitivity to LM or peppermint oil.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate whether LM causes the specific change and whether the atrophic gastritis is associated with the change
- Secondary Outcome Measures
Name Time Method To investigate the impact on the diagnosis of gastric lesions and evaluate anti-peristaltic effect of the LM solution
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does L-menthol application modulate TRPM8 receptor signaling in gastric mucosal repair for atrophic gastritis?
What is the efficacy comparison of L-menthol spray versus proton pump inhibitors in healing gastric atrophy?
Which biomarkers predict response to L-menthol-induced gastric mucosal regeneration in H. pylori-associated atrophic gastritis?
What are the safety profiles and management strategies for L-menthol mucosal application in chronic gastritis?
How does L-menthol combination therapy synergize with standard mucosal protectants in atrophic gastritis treatment?